Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses

Autoři: Christopher Cai aff001;  Jackson Runte aff001;  Isabel Ostrer aff001;  Kacey Berry aff001;  Ninez Ponce aff002;  Michael Rodriguez aff003;  Stefano Bertozzi aff004;  Justin S. White aff001;  James G. Kahn aff001
Působiště autorů: UCSF School of Medicine, University of California, San Francisco, San Francisco, California, United States of America aff001;  UCLA Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California, United States of America aff002;  David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California, United States of America aff003;  School of Public Health, University of California Berkeley, Berkeley, California, United States of America aff004
Vyšlo v časopise: Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses. PLoS Med 17(1): e1003013. doi:10.1371/journal.pmed.1003013
Kategorie: Research Article
doi: 10.1371/journal.pmed.1003013



The United States is the only high-income nation without universal, government-funded or -mandated health insurance employing a unified payment system. The US multi-payer system leaves residents uninsured or underinsured, despite overall healthcare costs far above other nations. Single-payer (often referred to as Medicare for All), a proposed policy solution since 1990, is receiving renewed press attention and popular support. Our review seeks to assess the projected cost impact of a single-payer approach.

Methods and findings

We conducted our literature search between June 1 and December 31, 2018, without start date restriction for included studies. We surveyed an expert panel and searched PubMed, Google, Google Scholar, and preexisting lists for formal economic studies of the projected costs of single-payer plans for the US or for individual states. Reviewer pairs extracted data on methods and findings using a template. We quantified changes in total costs standardized to percentage of contemporaneous healthcare spending. Additionally, we quantified cost changes by subtype, such as costs due to increased healthcare utilization and savings due to simplified payment administration, lower drug costs, and other factors. We further examined how modeling assumptions affected results. Our search yielded economic analyses of the cost of 22 single-payer plans over the past 30 years. Exclusions were due to inadequate technical data or assuming a substantial ongoing role for private insurers. We found that 19 (86%) of the analyses predicted net savings (median net result was a savings of 3.46% of total costs) in the first year of program operation and 20 (91%) predicted savings over several years; anticipated growth rates would result in long-term net savings for all plans. The largest source of savings was simplified payment administration (median 8.8%), and the best predictors of net savings were the magnitude of utilization increase, and savings on administration and drug costs (R2 of 0.035, 0.43, and 0.62, respectively). Only drug cost savings remained significant in multivariate analysis. Included studies were heterogeneous in methods, which precluded us from conducting a formal meta-analysis.


In this systematic review, we found a high degree of analytic consensus for the fiscal feasibility of a single-payer approach in the US. Actual costs will depend on plan features and implementation. Future research should refine estimates of the effects of coverage expansion on utilization, evaluate provider administrative costs in varied existing single-payer systems, analyze implementation options, and evaluate US-based single-payer programs, as available.

Klíčová slova:

Drug administration – Economic models – Finance – Health economics – Insurance – Medicare – Payment – Pharmacoeconomics


1. Tolbert J, Orgera K, Singer N, Damico A. Key facts about the uninsured population. San Francisco Kaiser Family Foundation; 2019 Dec 13 [cited 2019 Dec 18].

2. Woolhandler S, Himmelstein DU. The relationship of health insurance and mortality: is lack of insurance deadly? Ann Intern Med. 2017;167(6):424–431. doi: 10.7326/M17-1403 28655034

3. Chen Z, Min J, Bian J, Wang M, Zhou L, Prosperi M. Risk of health morbidity for the uninsured: 10-year evidence from a large hospital center in Boston, Massachusetts. Int J Qual Health Care. 2018;31(5):325–3.

4. Christopher AS, McCormick D, Woolhandler S, Himmelstein DU, Bor DH, Wilper AP. Access to care and chronic disease outcomes among Medicaid-insured persons versus the uninsured. Am J Public Health. 2016;106(1):63–9. doi: 10.2105/AJPH.2015.302925 26562119

5. McWilliam JM. Health consequences of uninsurance among adults in the United States: recent evidence and implications. Milbank Q. 2009;87(2):443–94. doi: 10.1111/j.1468-0009.2009.00564.x 19523125

6. Kaiser Family Foundation. 2018 Employer health benefits survey. Oakland (CA): Kaiser Family Foundation; 2018 [cited 2019 Dec 24].

7. Collins SR, Rasmussen PW, Beutel S, Doty MM. The problem of underinsurance and how rising deductibles will make it worse: findings from the Commonwealth Fund Biennial Health Insurance Survey, 2014. New York: Commonwealth Fund; 2015.

8. Nguyen KH, Sommers BD. Access and quality of care by insurance type for low-income adults before the Affordable Care Act. Am J Public Health. 2016;106(8):1409–15. doi: 10.2105/AJPH.2016.303156 27196646

9. Center for Medicare and Medicaid Services. National health expenditure data: historical. Baltimore: Center for Medicare and Medicaid Services; 2019 [cited 2019 Dec 18].

10. Himmelstein DU, Woolhandler S. The current and projected taxpayer shares of US health costs. Am J Public Health. 2016;106(3):449–52. doi: 10.2105/AJPH.2015.302997 26794173

11. Anderson GF, Hussey P, Petrosyan V. It’s still the prices, stupid: why the US spends so much on health care, and a tribute to Uwe Reinhardt. Health Aff (Millwood). 2019;38(1):87–95.

12. Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA. 2018;319(10):1024–39. doi: 10.1001/jama.2018.1150 29536101

13. Jiwani A, Himmelstein D, Woolhandler S, Kahn JG. Billing and insurance-related administrative costs in United States’ health care: Synthesis of micro-costing evidence. BMC Health Serv Res. 2014;14(1):556.

14. Stein L, Cornwell S, Tanfani J. Inside the progressive movement roiling the Democratic Party. Reuters. 2018 Aug 23 [cited 2019 Dec 18].

15. Serafini M. Why clinicians support single-payer—and who will win and lose. NEJM Catalyst. 2018 Jan 17.

16. POLITICO, Harvard T.H. Chan School of Public Health. Americans’ health and education priorities for the new congress in 2019. Boston: Harvard T.H. Chan School of Public Health; 2019 Jan [cited 2019 Dec 18].

17. Kaiser Family Foundation. Public opinion on single-payer, national health plans, and expanding access to Medicare coverage. Kaiser Family Foundation; 2019 Nov 26 [cited 2019 Dec 18].

18. Pollin R, Heintz J, Arno P, Wicks-Lim J, Ash M. Economic analysis of Medicare for All. Amherst (MA): Political Economy Research Institute, University of Massachusetts Amherst; 2018 Nov 30 [cited 2019 Dec 18].

19. Blahous C. The costs of a national single-payer healthcare system. Arlington (VA): Mercatus Center, George Mason University; 2018 Jul [cited 2019 Dec 18].

20. Holahan J, Buettgens M, Clemans-Cope L, Favreault MM, Blumberg LJ, Ndwandwe S. The Sanders single-payer health care plan: the effect on national health expenditures and federal and private spending. Washington (DC): Urban Institute; 2016 May 9 [cited 2019 Dec 18].

21. Hellander I. How much would single payer cost? A summary of studies compiled by Ida Hellander, M.D. Chicago: Physicians for a National Health Program; 2019 [cited 2019 Dec 18].

22. Healthcare-NOW. Listing of single payer studies. Boston: Healthcare-NOW; 2019 [cited 2019 Dec 18].

23. Center for American Progress. Medicare Extra for All: a plan to guarantee universal health coverage in the United States. Washington (DC): Center for American Progress; 2018 Feb 22 [cited 2019 Dec 18].

24. Thorpe KE. An analysis of Senator Sanders single payer plan. Boston: Healthcare-NOW; 2016 [cited 2019 Dec 29].

25. Lau JS, Adams SH, Park MJ, Boscardin WJ, Irwin CE. Improvement in preventive care of young adults after the Affordable Care Act: the Affordable Care Act is helping. JAMA Pediatr. 2014;168(12):1101–6. doi: 10.1001/jamapediatrics.2014.1691 25347766

26. Buchmueller TC, Grumbach K, Kronick R, Kahn JG. The effect of health insurance on medical care utilization and implications for insurance expansion: a review of the literature. Med Care Res Rev. 2005;62(1):3–30. doi: 10.1177/1077558704271718 15643027

27. Cheng SH, Chiang TL. The effect of universal health insurance on health care utilization in Taiwan. JAMA. 1997;278(2):89–93. 9214512

28. Pickens G, Karaca Z, Cutler E, Dworsky M, Eibner C, Moore B, et al. Changes in hospital inpatient utilization following health care reform. Health Serv Res. 2018;53(4):2446–69. doi: 10.1111/1475-6773.12734 28664983

29. Mahendraratnam N, Dusetzina SB, Farley JF. Prescription drug utilization and reimbursement increased following state Medicaid expansion in 2014. J Manage Care Spec Pharm. 2017;23(3):355–63.

30. Ku L. Medical and dental care utilization and expenditures under Medicaid and private health insurance. Med Care Res Rev. 2009;66(4):456–71. doi: 10.1177/1077558709334896 19389727

31. Hadley J, Holahan J. Is health care spending higher under Medicaid or private insurance? Inquiry. 2003;40(4):323–42. doi: 10.5034/inquiryjrnl_40.4.323 15055833

32. Kaiser Family Foundation. When high deductibles hurt: even insured patients postpone care. San Francisco: Kaiser Family Foundation; 2017 Jul 28 [cited 2019 Dec 18].

33. Fauke C, Himmelstein D. Doubling down on errors: Urban Institute defends its ridiculously high single payer cost estimates. HuffPost. 2017 Dec 6 [cited 2019 Dec 18].

34. Gaffney A, Woolhandler S, Himmelstein D. The effect of large-scale health coverage expansions in wealthy nations on society-wide healthcare utilization. J Gen Intern Med. 2019 Nov 19. doi: 10.1007/s11606-019-05529-y 31745857

35. Gaffney A, McCormick D, Bor D, Woolhandler S, Himmelstein D. Coverage expansions and utilization of physician care: evidence from the 2014 Affordable Care Act and 1966 Medicare/Medicaid expansions. Am J Public Health. 2019;109(12):1694–701. doi: 10.2105/AJPH.2019.305330 31622135

36. Simon K, Soni A, Cawley J. The impact of health insurance on preventive care and health behaviors: evidence from the first two years of the ACA Medicaid expansions. J Policy Anal Manage. 2017;36(2):390–417. doi: 10.1002/pam.21972 28378959

37. Himmelstein DU, Jun M, Busse R, Chevreul K, Geissler A, Jeurissen PPT, et al. A comparison of hospital administrative costs in eight nations: US costs exceed all others by far. Health Aff (Millwood). 2014;33(9):1586–94.

38. Gaffney A, Lexchin J. Healing an ailing pharmaceutical system: prescription for reform for United States and Canada. BMJ. 2018;361:k1039. doi: 10.1136/bmj.k1039 29773533

39. Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA. 2016;316(8):858–71. doi: 10.1001/jama.2016.11237 27552619

40. Hogervorst M. A qualitative and quantitative assessment on drug pricing methods in a single-payer system in the U.S. [master’s thesis]. Utrecht: Utrecht University; 2019.

41. Patented Medicine Prices Review Board. Annual report 2016. Ottawa: Patented Medicine Prices Review Board; 2017 [cited 2019 Dec 19].

42. Lanthier M, Miller KL, Nardinelli C, Woodcock J. An improved approach to measuring drug innovation finds steady rates of first-in-class pharmaceuticals, 1987–2011. Health Aff (Millwood). 2013;32(8):1433–9.

43. Prasad V, Mailankody S. Research and development spending to bring a single cancer drug to market and revenues after approval. JAMA Intern Med. 2017;177(11):1569–75. doi: 10.1001/jamainternmed.2017.3601 28892524

44. Drug Channels. Profits in the 2019 Fortune 500: manufacturers vs. managed care vs. pharmacies, PBMs, and wholesalers. Philadelphia: Drug Channels; 2019 Aug 27 [cited 2019 Dec 29].

45. Fox J. Corporate profits are down, but wages are up. New York: Bloomberg; 2019 Sep 1 [cited 2019 Dec 29].

46. Frakt AB, Pizer SD, Feldman R. Should Medicare adopt the Veterans Health Administration formulary? Health Econ. 2012;21(5):485–95. doi: 10.1002/hec.1733 21506191

47. Young PL, Saunders RS, Olsen L. The healthcare imperative: lowering costs and improving outcomes: workshop series summary. Washington (DC): National Academies Press; 2010.

48. Chisholm D, Evans DB. Improving health system efficiency as a means of moving towards universal coverage. Geneva: World Health Organization; 2010 [cited 2019 Dec 19].

49. Sullivan K. Seema Verma hyperventilates about tiny differences between ACOs exposed to one-and two-sided risk. The Health Care Blog. 2018 Aug 21 [cited 2019 Dec 19].

50. Verma S. Pathways to success: a new start for Medicare’s accountable care organizations. Health Affairs Blog. 2018 Aug 9 [cited 2019 Dec 19].

51. Medicare Payment Advisory Commission. Report to Congress: Medicare and the healthcare delivery system. Washington (DC): Medicare Payment Advisory Commission; 2018 Jun 15 [cited 2019 Dec 19].

52. Office of Inspector General. Medicare shared savings program accountable care organizations have shown potential for reducing spending and increasing quality. Washington (DC): Department of Health and Human Services; 2017 Aug [cited 2019 Dec 19].

53. Bleser WK, Muhlestein D, Saunders RS, McClellan MB. Half a decade in, Medicare accountable care organizations are generating net savings: Part 1. Health Affairs Blog. 2018 Sep 20 [cited 2019 Dec 19].

54. McWilliams JM, Hatfield LA, Landon BE, Hamed P, Chernew ME. Medicare spending after 3 years of the Medicare shared savings program. N Engl J Med. 2018;379(12):1139–49. doi: 10.1056/NEJMsa1803388 30183495

55. Joanna Briggs Institute. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews: checklist for economic evaluations. Adelaide: Joanna Briggs Institute; 2017 [cited 2019 Dec 19].

56. Wolff RF, Moons KG, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170:51–8. doi: 10.7326/M18-1376 30596875

57. Langer A. A framework for assessing Health Economic Evaluation (HEE) quality appraisal instruments. BMC Health Serv Res. 2012;12:253. doi: 10.1186/1472-6963-12-253 22894708

58. Lewin Group. Cost and coverage analysis of nine proposals to expand health insurance coverage in California. Falls Church (VA): Lewin Group; 2002 Apr 12 [cited 2019 Dec 19].

59. Haber S, Beil H, Amico P, Morrison M, Akhmerova V, Beadles C, et al. Evaluation of the Maryland all-payer model: third annual report. Waltham (MA): RTI International; 2018 [cited 2019 Dec 19].

60. Ikegami N, editor. Universal health coverage for inclusive and sustainable development: lessons from Japan. Washington (DC): World Bank; 2014 [cited 2019 Dec 19].

61. Figueras J, Robinson R, Jakubowski E, editors. Purchasing to improve health systems performance. European Observatory on Health Systems and Policies Series. Geneva: World Health Organization; 2005 [cited 2019 Dec 19].

62. Liu J, Eibner C. National health spending estimates under Medicare for All. Santa Monica (CA): RAND; 2019 [cited 2019 Dec 19].

Interní lékařství

Článek vyšel v časopise

PLOS Medicine

2020 Číslo 1
Nejčtenější tento týden
Nejčtenější v tomto čísle

Zvyšte si kvalifikaci online z pohodlí domova

Konsenzuální postupy v léčbě močových infekcí
nový kurz

Hereditární TTR amyloidóza – vzácné, nebo jen neodhalené onemocnění? 2. díl

Současné možnosti v léčbě psoriázy

Svět praktické medicíny 4/2022 (znalostní test z časopisu)

COVID-19 up to date
Autoři: doc. MUDr. Vladimír Koblížek, Ph.D., MUDr. Mikuláš Skála, prof. MUDr. František Kopřiva, Ph.D., prof. MUDr. Roman Prymula, CSc., Ph.D.

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.


Nemáte účet?  Registrujte se